What are the pharmacotherapeutic considerations for the treatment of myasthenia gravis?

被引：6
作者：
Vanoli, Fiammetta [1 ,2 ]
Mantegazza, Renato [1 ]
机构：
[1] Fdn IRCCS Ist Neurol Carlo Besta, Neuroimmunol & Neuromuscular Dis Dept, Milan, Italy
[2] Sapienza Univ Rome, Dept Human Neurosci, Rome, Italy
来源：
EXPERT OPINION ON PHARMACOTHERAPY | 2022年 / 23卷 / 13期
关键词：
Myasthenia gravis; monoclonal antibodies; immunosuppression; biological drugs; C5; FcRn; RITUXIMAB;
D O I：
10.1080/14656566.2022.2122710
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：1471 / 1474
页数：4
相关论文
共 17 条
  • [1] ClinicalTrials.gov, EFG EXP ACC GEN MYAS
  • [2] Long-lasting treatment effect of rituximab in MuSK myasthenia
    Diaz-Manera, J.
    Martinez-Hernandez, E.
    Querol, L.
    Klooster, R.
    Rojas-Garcia, R.
    Suarez-Calvet, X.
    Munoz-Blanco, J. L.
    Mazia, C.
    Straasheijm, K. R.
    Gallardo, E.
    Juarez, C.
    Verschuuren, J. J.
    Illa, I.
    [J]. NEUROLOGY, 2012, 78 (03) : 189 - 193
  • [3] Myasthenia gravis
    Gilhus, Nils Erik
    Tzartos, Socrates
    Evoli, Amelia
    Palaces, Jacqueline
    Burns, Ted M.
    Verschuuren, Jan J. G. M.
    [J]. NATURE REVIEWS DISEASE PRIMERS, 2019, 5
  • [4] Maintenance immunosuppression in myasthenia gravis
    Gotterer, Lauren
    Li, Yuebing
    [J]. JOURNAL OF THE NEUROLOGICAL SCIENCES, 2016, 369 : 294 - 302
  • [5] Randomized study of adjunctive belimumab in participants with generalized myasthenia gravis
    Hewett, Karen
    Sanders, Donald B.
    Grove, Richard A.
    Broderick, Christine L.
    Rudo, Todd J.
    Bassiri, Ashlyn
    Zvartau-Hind, Marina
    Bril, Vera
    [J]. NEUROLOGY, 2018, 90 (16) : E1425 - E1434
  • [6] Long-term efficacy of eculizumab in refractory generalized myasthenia gravis: responder analyses
    Howard, James F., Jr.
    Karam, Chafic
    Yountz, Marcus
    O'Brien, Fanny L.
    Mozaffar, Tahseen
    [J]. ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY, 2021, 8 (07): : 1398 - 1407
  • [7] Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study
    Howard, James F., Jr.
    Utsugisawa, Kimiaki
    Benatar, Michael
    Murai, Hiroyuki
    Barohn, Richard J.
    Illa, Isabel
    Jacob, Saiju
    Vissing, John
    Burns, Ted M.
    Kissel, John T.
    Muppidi, Srikanth
    Nowak, Richard J.
    O'Brien, Fanny
    Wang, Jing-Jing
    Mantegazza, Renato
    Mazia, Claudio Gabriel
    Wilken, Miguel
    Ortea, Carolina
    Saba, Juliet
    Rugiero, Marcelo
    Bettini, Mariela
    Vidal, Gonzalo
    Garcia, Alejandra Dalila
    Lamont, Phillipa
    Leong, Wai-Kuen
    Boterhoven, Heidi
    Fyfe, Beverly
    Roberts, Leslie
    Jasinarachchi, Mahi
    Willlems, Natasha
    Wanschitz, Julia
    Loscher, Wolfgang
    De Bleecker, Jan
    Van den Abeele, Guy
    de Koning, Kathy
    De Mey, Katrien
    Mercelis, Rudy
    Wagemaekers, Linda
    Mahieu, Delphine
    Van Damme, Philip
    Smetcoren, Charlotte
    Stevens, Olivier
    Verjans, Sarah
    D'Hondt, Ann
    Tilkin, Petra
    Alves de Siqueira Carvalho, Alzira
    Hasan, Rosa
    Brockhausen, Igor Dias
    Feder, David
    Ambrosio, Daniel
    [J]. LANCET NEUROLOGY, 2017, 16 (12) : 976 - 986
  • [8] Safety, efficacy, and tolerability of efgartigimod in patients with generalised myasthenia gravis (ADAPT) : a multicentre, randomised, placebo-controlled, phase 3 trial
    Howard, James F. Jr Jr
    Bril, Vera
    Vu, Tuan
    Karam, Chafic
    Perk, Stojan
    Margania, Temur
    Murai, Hiroyuki
    Bilinska, Malgorzata
    Shakarishvili, Roman
    Smilowski, Marek
    Guglietta, Antonio
    Ulrichts, Peter
    Vangeneugden, Tony
    Utsugisawa, Kimiaki
    Verschuuren, Jan
    Mantegazza, Renato
    [J]. LANCET NEUROLOGY, 2021, 20 (07) : 526 - 536
  • [9] B-cell subpopulations in humans and their differential susceptibility to depletion with anti-CD20 monoclonal antibodies
    Leandro, Maria J.
    [J]. ARTHRITIS RESEARCH & THERAPY, 2013, 15
  • [10] International Consensus Guidance for Management of Myasthenia Gravis 2020 Update
    Narayanaswami, Pushpa
    Sanders, Donald B.
    Wolfe, Gil
    Benatar, Michael
    Cea, Gabriel
    Evoli, Amelia
    Gilhus, Nils Erik
    Illa, Isabel
    Kuntz, Nancy L.
    Massey, Janice
    Melms, Arthur
    Murai, Hiroyuki
    Nicolle, Michael
    Palace, Jacqueline
    Richman, David
    Verschuuren, Jan
    [J]. NEUROLOGY, 2021, 96 (03) : 114 - 122
12